Contact Us
Generic Pharmaceuticals Global Market Report 2025
Global Generic Pharmaceuticals Market Report 2025

Report Price : $4490.00

Pages : 250

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Generic Pharmaceuticals Global Market Report 2025

By Type (Biosimilars, Generics), By Drug Delivery (Oral, Injectables, Dermal/Topical, Inhaled), By Therapy (CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, Biosimilars, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, And Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Generic Pharmaceuticals Market?

Generic pharmaceuticals refer to a drug that was developed to have the same dosage form, safety, strength, mode of administration, quality, performance attributes, and intended use as an already marketed brand-name drug. The action and clinical benefits of a generic drug are identical to those of a brand-name drug.

The three main types of generic pharmaceuticals are biosimilar, and generic. A biosimilar is a biological product that is very similar to a reference biologic and has no clinically significant differences in terms of safety, purity, or potency. The drugs are delivered through oral, injectable, dermal/topical, and inhalers that are used for various therapies such as CNS, cardiovascular, dermatology, genitourinary/hormonal, respiratory, rheumatology, diabetes, biosimilars, and oncology. The various distribution channels involved is hospital pharmacies, retail pharmacies, and online pharmacies.

Generic Pharmaceuticals Market 2025 - 2034

What Is The Generic Pharmaceuticals Market Size 2025 And Growth Rate?

The generic pharmaceuticals market size has grown strongly in recent years. It will grow from $457.04 billion in 2024 to $492.16 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to rise in healthcare awareness and expenditure, patent expiration of drugs, increased prevalence of respiratory diseases, changes in lifestyles, increased number of surgical procedures, strong economic growth in emerging markets, increase in insurance coverage, rapid growth in elderly population, increased number of approvals.

What Is The Generic Pharmaceuticals Market Growth Forecast?

The generic pharmaceuticals market size is expected to see strong growth in the next few years. It will grow to $666.48 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing rising incidence of chronic diseases, rising regulators support, new methods for drug discovery, new methods for drug delivery and monitoring, rise in healthcare expenditure, increasing geriatric population, and major drug patents. Major trends in the forecast period include increasing use of 3D printing, adopting the use of artificial intelligence (ai), using biomarkers for drug development, collaborations for driving innovation, combination drug therapy, modification of existing epilepsy drugs, and rise of generic respiratory drugs.

Customer representative image Book your 30 minutes free consultation with our research experts

How Is The Generic Pharmaceuticals Market Segmented?

The generic pharmaceuticals market covered in this report is segmented –

1) By Type: Biosimilars, Generics

2) By Drug Delivery: Oral, Injectables, Dermal/Topical, Inhaled

3) By Therapy: CNS, Cardiovascular, Dermatology, Genitourinary/Harmonal, Respiratory, Rheumatology, Diabetes, Oncology, Biosimilars, Others

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, And Online Pharmacies

Subsegments:

1) By Biosimilars: Monoclonal Antibodies, recombinant proteins, Other Biologic Products

2) By Generics: Branded Generics, Generic Small Molecules, Generic Extended-Release Formulations, Over-The-Counter (OTC) Generics

What Is Driving The Generic Pharmaceuticals Market? Rising Incidence Of Chronic Diseases Driving The Generic Pharmaceuticals Market

The rising incidence of chronic diseases is one of the major drivers of the generic pharmaceuticals market. As more individuals are diagnosed with chronic diseases, they look for more medicines for treatment. Branded drugs come at a premium price, while generic drugs are available at a lower cost and have the same chemical composition as branded drugs. The low cost and same chemical composition and strength of generic drugs make a patient buy generic drugs instead of branded drugs. If IT is a chronic disease, the treatment goes on for a longer period, and hence, the sales of generic drugs also increase. For instance, according to the WHO (World Health Organization), over the next 10 years, the number of deaths due to chronic disease is projected to increase by 17%. Therefore rising incidence of chronic diseases is one of the major drivers of the generic pharmaceuticals market.

What Is Driving The Generic Pharmaceuticals Market? Cost-Effective Treatment With Generic Drugs Driving The Generic Pharmaceutical Market

Cost-effective treatment from generic drugs is expected to propel the growth of the generic pharmaceutical market going forward. Cost-effective treatment refers to a treatment option that provides a high level of health benefits at a reasonable cost. Generic drugs are a cost-effective treatment option for patients, and they provide significant cost savings for the healthcare system and are significantly less expensive than branded drugs. For instance, in March 2024, according to the Assistant Secretary for Planning and Evaluation (ASPE), a U.S.-based principal advisory group, in 2022, 43.3 million Medicare Part D enrollees, the individuals who are enrolled in Medicare's prescription drug benefit program, known as Medicare Part D representing 82 percent of participants, filled 1.1 billion prescriptions for generic drugs. This resulted in $5.7 billion in out-of-pocket (OOP) expenses for patients and $32.9 billion in gross drug costs. Therefore, cost-effective treatment with generic drugs is driving the growth of the generic pharmaceutical market..

Who Are The Major Players In The Global Generic Pharmaceuticals Market?

Major companies operating in the generic pharmaceuticals market include Teva Pharmaceutical Industries Ltd., Novartis AG, Sun Pharmaceutical Industries Ltd., Fresenius Kabi, Aurobindo Pharma Limited, Cipla Limited, Stada Arzneimittel AG, Lupin Pharmaceuticals, Inc., Dr. Reddy's Laboratories, Mylan Inc., Shanghai Generic Pharmaceuticals, Shanghai Acebright Generic Pharmaceuticals Group Co., Ltd., Sandoz, Glenmark, Kent Pharma, Zentiva, Apotex, Accord Healthcare Inc., Acerus Pharmaceutical Drugs Corporation, AA Pharma Inc, LABORATORIOS SENOSIAIN SA DE CV (Senosiain), Siegfried Rhein, EMS Pharma, Hypermarcas, Eurofarma, Teuto Brasileiro, Biolab Farmaceutica, Cristalia, União Quimica, Boehringer Ingelheim, Mantecorp Farmasa, Libbs, Cimed, FQM Grupo, Spimaco, Jamjoom Pharma, Tabuk Pharmaceutical Manufacturing, Jazeera Pharmaceutical Industries, Adcock Ingram, Eurolab, Ranbaxy (Pty) Ltd, Aspen

What Are The Key Trends Of The Global Generic Pharmaceuticals Market? Revolutionizing Generic Pharmaceuticals Manufacturing With 3D Printing Technology

3D printing technology can transform the manufacturing of drugs in the generic pharmaceuticals market. 3D printed pharmaceuticals help improve R&D productivity and deliver new benefits to patients. 3D printing allows the manufacturer to produce drugs with customized size, shape, and texture, which is not possible in traditional manufacturing of generic drugs. 3D printing can help the manufacturer to make generic drugs that have different release dates, appearances, and tastes. For example, GlaxoSmithKline (GSK) completed a study where ultraviolet (UV) and 3D printing were used to manufacture tablets to treat Parkinson's disease. Martin Wallace, director of GSK Technology, said that GSK is investing in 3D printing to manufacture pills and tablets. Also, Aprecia pharmaceutical company launched'ZipDose' technology, which manufactures 3D printed drugs.

What Are The Key Trends Of The Global Generic Pharmaceuticals Market? Generic Pharmaceutical Portfolios To Maximize Profits

Major companies operating in the generic pharmaceuticals market are integrating new efforts into introducing new generic pharmaceutical products to maximize their profits in the market. Introducing generic pharmaceutical products refers to the process of introducing a generic version of a brand-name drug to the market. For instance, in July 2023, Amneal Pharmaceuticals Inc., a US-based publicly traded generics and specialty pharmaceutical company, launched its authorized generic for Xyrem 1 (Sodium Oxybate) oral solution CIII in the United States. Sodium oxybate oral solution, 0.5 g/mL, is a central nervous system depressant that is prescribed for narcoleptic patients seven years of age and older who experience cataplexy or excessive daytime sleepiness (EDS).

Need data on a specific region in this market?

Generic Pharmaceuticals Market Merger And Acquisition: Dr. Reddy's Laboratories Acquires Injectable Products From Eton Pharma To Expand Branded Generics And Biosimilars

In June 2022, Dr. Reddy's Laboratories, an India-based pharmaceutical company that provides branded generics acquired branded and generic injectable products from Eton Pharma for $50 million. With this acquisition, Dr. Reddy's Laboratories aims to accelerate and expand affordable medications for patients with branded generics such as Biorphen (phenylephrine hydrochloride) injection and Rezipres and launch biosimilars. Eton Pharmaceuticals, Inc., a US-based pharmaceutical company that provides generic pharmaceuticals.

Regional Outlook For The Global Generic Pharmaceuticals Market

North America was the largest region in the generic pharmaceuticals market in 2024. Middle East is expected to be the fastest-growing region in the generic pharmaceuticals market report during the forecast period. The regions covered in the generic pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the generic pharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

What Defines the Generic Pharmaceuticals Market?

The generic pharmaceuticals market consists of sales of paracetamol, cefixime, amoxicillin, and ofloxacin. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Generic Pharmaceuticals Industry?

The generic pharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides generic pharmaceuticals market statistics, including generic pharmaceuticals industry global market size, regional shares, competitors with a generic pharmaceuticals market share, detailed generic pharmaceuticals market segments, market trends and opportunities, and any further data you may need to thrive in the generic pharmaceuticals industry. The generic pharmaceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Generic Pharmaceuticals Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $492.16 billion
Revenue Forecast In 2034 $666.48 billion
Growth Rate CAGR of 7.9% from 2024 to 2033
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Biosimilars, Generics
2) By Drug Delivery: Oral, Injectables, Dermal/Topical, Inhaled
3) By Therapy: CNS, Cardiovascular, Dermatology, Genitourinary/Harmonal, Respiratory, Rheumatology, Diabetes, Oncology, Biosimilars, Others
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, And Online Pharmacies Subsegments: 1) By Biosimilars: Monoclonal Antibodies, Recombinant Proteins, Other Biologic Products
2) By Generics: Branded Generics, Generic Small Molecules, Generic Extended-Release Formulations, Over-The-Counter (OTC) Generics
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Teva Pharmaceutical Industries Ltd., Novartis AG, Sun Pharmaceutical Industries Ltd., Fresenius Kabi, Aurobindo Pharma Limited, Cipla Limited, Stada Arzneimittel AG, Lupin Pharmaceuticals, Inc., Dr. Reddy's Laboratories, Mylan Inc., Shanghai Generic Pharmaceuticals, Shanghai Acebright Generic Pharmaceuticals Group Co., Ltd., Sandoz, Glenmark, Kent Pharma, Zentiva, Apotex, Accord Healthcare Inc., Acerus Pharmaceutical Drugs Corporation, AA Pharma Inc, LABORATORIOS SENOSIAIN SA DE CV (Senosiain), Siegfried Rhein, EMS Pharma, Hypermarcas, Eurofarma, Teuto Brasileiro, Biolab Farmaceutica, Cristalia, União Quimica, Boehringer Ingelheim, Mantecorp Farmasa, Libbs, Cimed, FQM Grupo, Spimaco, Jamjoom Pharma, Tabuk Pharmaceutical Manufacturing, Jazeera Pharmaceutical Industries, Adcock Ingram, Eurolab, Ranbaxy (Pty) Ltd, Aspen
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Generic Pharmaceuticals Market Characteristics

3. Generic Pharmaceuticals Market Trends And Strategies

4. Generic Pharmaceuticals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Generic Pharmaceuticals Growth Analysis And Strategic Analysis Framework

5.1. Global Generic Pharmaceuticals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Generic Pharmaceuticals Market Growth Rate Analysis

5.4. Global Generic Pharmaceuticals Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Generic Pharmaceuticals Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Generic Pharmaceuticals Total Addressable Market (TAM)

6. Generic Pharmaceuticals Market Segmentation

6.1. Global Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Biosimilar

Generics

6.2. Global Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Inectables

Dermal/Topical

6.3. Global Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

CNS

Cardiovascular

Dermatology

Genitourinary/Harmonal

Respiratory

Rheumatology

Diabetes

Oncology

Inhaler

6.4. Global Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

6.5. Global Generic Pharmaceuticals Market, Sub-Segmentation Of Biosimilars, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Monoclonal Antibodies

Recombinant Proteins

Other Biologic Products

6.6. Global Generic Pharmaceuticals Market, Sub-Segmentation Of Generics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Branded Generics

Generic Small Molecules

Generic Extended-Release Formulations

Over-The-Counter (OTC) Generics

7. Generic Pharmaceuticals Market Regional And Country Analysis

7.1. Global Generic Pharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Generic Pharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Generic Pharmaceuticals Market

8.1. Asia-Pacific Generic Pharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Generic Pharmaceuticals Market

9.1. China Generic Pharmaceuticals Market Overview

9.2. China Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Generic Pharmaceuticals Market

10.1. India Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Generic Pharmaceuticals Market

11.1. Japan Generic Pharmaceuticals Market Overview

11.2. Japan Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Generic Pharmaceuticals Market

12.1. Australia Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Generic Pharmaceuticals Market

13.1. Indonesia Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Generic Pharmaceuticals Market

14.1. South Korea Generic Pharmaceuticals Market Overview

14.2. South Korea Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Generic Pharmaceuticals Market

15.1. Western Europe Generic Pharmaceuticals Market Overview

15.2. Western Europe Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Generic Pharmaceuticals Market

16.1. UK Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Generic Pharmaceuticals Market

17.1. Germany Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Generic Pharmaceuticals Market

18.1. France Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Generic Pharmaceuticals Market

19.1. Italy Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Generic Pharmaceuticals Market

20.1. Spain Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Generic Pharmaceuticals Market

21.1. Eastern Europe Generic Pharmaceuticals Market Overview

21.2. Eastern Europe Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Generic Pharmaceuticals Market

22.1. Russia Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Generic Pharmaceuticals Market

23.1. North America Generic Pharmaceuticals Market Overview

23.2. North America Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Generic Pharmaceuticals Market

24.1. USA Generic Pharmaceuticals Market Overview

24.2. USA Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Generic Pharmaceuticals Market

25.1. Canada Generic Pharmaceuticals Market Overview

25.2. Canada Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Generic Pharmaceuticals Market

26.1. South America Generic Pharmaceuticals Market Overview

26.2. South America Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Generic Pharmaceuticals Market

27.1. Brazil Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Generic Pharmaceuticals Market

28.1. Middle East Generic Pharmaceuticals Market Overview

28.2. Middle East Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Generic Pharmaceuticals Market

29.1. Africa Generic Pharmaceuticals Market Overview

29.2. Africa Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Generic Pharmaceuticals Market Competitive Landscape And Company Profiles

30.1. Generic Pharmaceuticals Market Competitive Landscape

30.2. Generic Pharmaceuticals Market Company Profiles

30.2.1. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Fresenius Kabi Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Aurobindo Pharma Limited Overview, Products and Services, Strategy and Financial Analysis

31. Generic Pharmaceuticals Market Other Major And Innovative Companies

31.1. Cipla Limited

31.2. Stada Arzneimittel AG

31.3. Lupin Pharmaceuticals, Inc.

31.4. Dr. Reddy's Laboratories

31.5. Mylan Inc.

31.6. Shanghai Generic Pharmaceuticals

31.7. Shanghai Acebright Generic Pharmaceuticals Group Co., Ltd.

31.8. Sandoz

31.9. Glenmark

31.10. Kent Pharma

31.11. Zentiva

31.12. Apotex

31.13. Accord Healthcare Inc.

31.14. Acerus Pharmaceutical Drugs Corporation

31.15. AA Pharma Inc

32. Global Generic Pharmaceuticals Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Generic Pharmaceuticals Market

34. Recent Developments In The Generic Pharmaceuticals Market

35. Generic Pharmaceuticals Market High Potential Countries, Segments and Strategies

35.1 Generic Pharmaceuticals Market In 2029 - Countries Offering Most New Opportunities

35.2 Generic Pharmaceuticals Market In 2029 - Segments Offering Most New Opportunities

35.3 Generic Pharmaceuticals Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

Need tailored insights? Customise this report to fit your business goals.


List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Generic Pharmaceuticals Market, Sub-Segmentation Of Biosimilars, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Generic Pharmaceuticals Market, Sub-Segmentation Of Generics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Generic Pharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Generic Pharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Teva Pharmaceutical Industries Ltd. Financial Performance
  • Table 78: Novartis AG Financial Performance
  • Table 79: Sun Pharmaceutical Industries Ltd. Financial Performance
  • Table 80: Fresenius Kabi Financial Performance
  • Table 81: Aurobindo Pharma Limited Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Generic Pharmaceuticals Market, Sub-Segmentation Of Biosimilars, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Generic Pharmaceuticals Market, Sub-Segmentation Of Generics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Generic Pharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Generic Pharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Teva Pharmaceutical Industries Ltd. Financial Performance
  • Figure 78: Novartis AG Financial Performance
  • Figure 79: Sun Pharmaceutical Industries Ltd. Financial Performance
  • Figure 80: Fresenius Kabi Financial Performance
  • Figure 81: Aurobindo Pharma Limited Financial Performance

Frequently Asked Questions

Generic pharmaceuticals refer to a drug that was developed to have the same dosage form, safety, strength, mode of administration, quality, performance attributes, and intended use as an already marketed brand-name drug. The action and clinical benefits of a generic drug are identical to those of a brand-name drug. For further insights on the Generic Pharmaceuticals market, request a sample here

The Generic Pharmaceuticals market major growth driver - Rising Incidence Of Chronic Diseases Driving The Generic Pharmaceuticals Market. For further insights on the Generic Pharmaceuticals market, request a sample here

The Generic Pharmaceuticals market size has grown strongly in recent years. The generic pharmaceuticals market size has grown strongly in recent years. It will grow from $457.04 billion in 2024 to $492.16 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to rise in healthcare awareness and expenditure, patent expiration of drugs, increased prevalence of respiratory diseases, changes in lifestyles, increased number of surgical procedures, strong economic growth in emerging markets, increase in insurance coverage, rapid growth in elderly population, increased number of approvals. The generic pharmaceuticals market size is expected to see strong growth in the next few years. It will grow to $666.48 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing rising incidence of chronic diseases, rising regulators support, new methods for drug discovery, new methods for drug delivery and monitoring, rise in healthcare expenditure, increasing geriatric population, and major drug patents. Major trends in the forecast period include increasing use of 3D printing, adopting the use of artificial intelligence (ai), using biomarkers for drug development, collaborations for driving innovation, combination drug therapy, modification of existing epilepsy drugs, and rise of generic respiratory drugs. For further insights on the Generic Pharmaceuticals market, request a sample here

The generic pharmaceuticals market covered in this report is segmented –
1) By Type: Biosimilars, Generics
2) By Drug Delivery: Oral, Injectables, Dermal/Topical, Inhaled
3) By Therapy: CNS, Cardiovascular, Dermatology, Genitourinary/Harmonal, Respiratory, Rheumatology, Diabetes, Oncology, Biosimilars, Others
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, And Online Pharmacies Subsegments:
1) By Biosimilars: Monoclonal Antibodies, Recombinant Proteins, Other Biologic Products
2) By Generics: Branded Generics, Generic Small Molecules, Generic Extended-Release Formulations, Over-The-Counter (OTC) Generics For further insights on the Generic Pharmaceuticals market,
request a sample here

North America was the largest region in the generic pharmaceuticals market in 2024. Middle East is expected to be the fastest-growing region in the generic pharmaceuticals market report during the forecast period. The regions covered in the generic pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the Generic Pharmaceuticals market, request a sample here.

Major companies operating in the generic pharmaceuticals market include Teva Pharmaceutical Industries Ltd., Novartis AG, Sun Pharmaceutical Industries Ltd., Fresenius Kabi, Aurobindo Pharma Limited, Cipla Limited, Stada Arzneimittel AG, Lupin Pharmaceuticals, Inc., Dr. Reddy's Laboratories, Mylan Inc., Shanghai Generic Pharmaceuticals, Shanghai Acebright Generic Pharmaceuticals Group Co., Ltd., Sandoz, Glenmark, Kent Pharma, Zentiva, Apotex, Accord Healthcare Inc., Acerus Pharmaceutical Drugs Corporation, AA Pharma Inc, LABORATORIOS SENOSIAIN SA DE CV (Senosiain), Siegfried Rhein, EMS Pharma, Hypermarcas, Eurofarma, Teuto Brasileiro, Biolab Farmaceutica, Cristalia, União Quimica, Boehringer Ingelheim, Mantecorp Farmasa, Libbs, Cimed, FQM Grupo, Spimaco, Jamjoom Pharma, Tabuk Pharmaceutical Manufacturing, Jazeera Pharmaceutical Industries, Adcock Ingram, Eurolab, Ranbaxy (Pty) Ltd, Aspen . For further insights on the Generic Pharmaceuticals market, request a sample here.

Major trends in the Generic Pharmaceuticals market include Revolutionizing Generic Pharmaceuticals Manufacturing With 3D Printing Technology. For further insights on the Generic Pharmaceuticals market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top
\
Back to top